发明名称 BICYCLIC HETEROCYCLIC COMPOUND
摘要 [Problem] To provide a compound useful as the active ingredient in a drug composition for treating diseases to which 11ß-hydroxysteroid dehydrogenase type 1 contributes such as dementia, schizophrenia, depression, pain (particularly neuropathic pain and fibromyalgia), diabetes (particularly type 2 diabetes), and insulin resistance. [Solution] It was discovered that a bicyclic heterocyclic compound substituted with an acylamino group such as a (hetero)aroylamino group (the bicyclic heterocycle being formed by condensing a cyclohexane ring and a 5- or 6-membered monocyclic heterocycle having only a nitrogen atom as the heteroatom) or a pharmaceutically acceptable salt thereof has a superior selective inhibitory action with respect to 11ß-HSD1. Thus, the bicyclic heterocyclic compound can be used in the treatment of dementia, schizophrenia, depression, pain (particularly neuropathic pain and fibromyalgia), diabetes (particularly type 2 diabetes), insulin resistance, and the like
申请公布号 CA2851589(A1) 申请公布日期 2013.04.25
申请号 CA20122851589 申请日期 2012.10.17
申请人 ASTELLAS PHARMA INC. 发明人 KAWAKAMI, SHIMPEI;SAKURAI, MINORU;KAWANO, NORIYUKI;SUZUKI, TAKAYUKI;SHIRAISHI, NOBUYUKI;HAMAGUCHI, WATARU;SEKIOKA, RYUICHI;MORITOMO, HIROYUKI;MORITOMO, AYAKO
分类号 C07D231/56;A61K31/416;A61K31/4184;A61K31/4192;A61K31/4245;A61K31/437;A61K31/4439;A61K31/4709;A61K31/497;A61K31/501;A61K31/502;A61K31/506;A61K31/517;A61K31/5377;A61P3/04;A61P3/06;A61P3/10;A61P19/10;A61P25/04;A61P25/18;A61P25/24;A61P25/28;A61P27/06;A61P43/00;C07D401/12;C07D401/14;C07D403/12;C07D403/14;C07D405/12;C07D405/14;C07D409/12;C07D409/14;C07D413/12;C07D417/14;C07D471/04 主分类号 C07D231/56
代理机构 代理人
主权项
地址